U.S. flag

An official website of the United States government

HLA–B*58:01 AND Allopurinol response

Germline classification:
not provided (1 submission)
Last evaluated:
Nov 13, 2012
Review status:
no classification provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000031851.1

Allele description [Variation Report for HLA–B*58:01]

HLA–B*58:01

Gene:
HLA-B:major histocompatibility complex, class I, B [Gene - OMIM - HGNC]
Variant type:
Variation
Cytogenetic location:
6p21.3
Preferred name:
HLA–B*58:01
Other names:
HLAB*58:01
Links:
OMIM: 142830.0004

Condition(s)

Name:
Allopurinol response
Synonyms:
Zyloprim response
Identifiers:
MedGen: CN160494

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000054459ClinVar Staff, National Center for Biotechnology Information (NCBI)
no classification provided
not providedgermlinecuration

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinVar Staff, National Center for Biotechnology Information (NCBI), SCV000054459.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024